Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC)

Short Report ◽

157: A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiotherapy (SABR) Plus Surgery in Operable Patients with Early Non-Small Cell Lung Cancer (Missile-NSCLC): Interim Safety Results

Radiotherapy and Oncology ◽

10.1016/s0167-8140(16)33556-3 ◽

2016 ◽

Vol 120 ◽

pp. S58

Author(s):

David Palma ◽

Keith Kwan ◽

Stewart Gaede ◽

Mark Landis ◽

Richard Malthaner ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Prospective, Risk-Adapted Strategy of Stereotactic Body Radiotherapy for Early-Stage Non–Small-Cell Lung Cancer: Results of a Phase II Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.04.056 ◽

2011 ◽

Vol 80 (5) ◽

pp. 1343-1349 ◽

Cited By ~ 119

Author(s):

Samuel Bral ◽

Thierry Gevaert ◽

Nadine Linthout ◽

Harijati Versmessen ◽

Christine Collen ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Stereotactic Body Radiotherapy ◽

Phase Ii Trial ◽

Early Stage ◽

Small Cell ◽

Small Cell Lung ◽

Prospective Risk

OA06.06 MISSILE-NSCLC: A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early-Stage Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.267 ◽

2018 ◽

Vol 13 (10) ◽

pp. S335 ◽

Cited By ~ 1

Author(s):

D. Palma ◽

A. Louie ◽

R. Malthaner ◽

D. Fortin ◽

G. Rodrigues ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Stereotactic Radiotherapy ◽

Phase Ii Trial ◽

Early Stage ◽

Small Cell ◽

327 Phase II trial of induction paclitaxel/carboplatin (PC) in early stage (T2NO, T1-2N1, and selected T3NO-1) non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(97)89706-1 ◽

1997 ◽

Vol 18 ◽

pp. 84 ◽

Cited By ~ 2

Author(s):

K.M.W. Pisters ◽

M.G. Kris ◽

P.A. Bunn ◽

J.J. Crowley ◽

R.J. Ginsberg

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Early Stage ◽

Small Cell ◽

Stereotactic Ablative Radiation Therapy

A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiation Therapy (SABR) Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE-NSCLC): Interim Safety Results

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.1818 ◽

2016 ◽

Vol 96 (2) ◽

pp. E473

Author(s):

D.A. Palma ◽

K. Kwan ◽

S. Gaede ◽

M. Landis ◽

R. Malthaner ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Early Stage ◽

Small Cell ◽

Small Cell Lung ◽

Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer

Cancer Investigation ◽

10.1080/07357900801944856 ◽

2009 ◽

pp. 1-1

Author(s):

A. R. Jazieh ◽

R. Komrokji ◽

A. Gupta ◽

S. Patil ◽

D. Flora ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer

Case Medical Research ◽

10.31525/ct1-nct04271384 ◽

2020 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Early Stage ◽

Small Cell ◽

P48.05 Anlotinib Plus Platinum-Etoposide in 1st-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Single-Arm Phase II Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.875 ◽

2021 ◽

Vol 16 (3) ◽

pp. S501

Author(s):

P. Deng ◽

H. Yang ◽

C. Chen ◽

C. Hu ◽

L. Cao ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

Extensive Stage

P82.02 Stereotactic Ablative Radiotherapy with Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer: a phase 2 study

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.1193 ◽

2021 ◽

Vol 16 (3) ◽

pp. S651-S652

Author(s):

J. Beal ◽

D. Gomes ◽

P. Taranto ◽

L. Koch ◽

A.C. Rezende ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Early Stage ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study

A retrospective study of clinicopathologic and molecular features of inoperable early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy

Journal of the Formosan Medical Association ◽

10.1016/j.jfma.2020.12.028 ◽

2021 ◽

Author(s):

I-Han Lee ◽

Guann-Yiing Chen ◽

Chun-Ru Chien ◽

Jason Chia-Hsien Cheng ◽

Jenny Ling-Yu Chen ◽

...

Keyword(s):

Lung Cancer ◽

Retrospective Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Early Stage ◽

Small Cell ◽

Small Cell Lung ◽

Molecular Features